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E-mail address: yossi@interchange.ubc.ca (Y. Av-GMycobacterium tuberculosis resides within alveolar macrophages. These phagocytes produce reac-
tive nitrogen and oxygen intermediates to combat the invading pathogens. The macrophage gluta-
thione (GSH) pool reduces nitric oxide (NO) to S-nitrosoglutathione (GSNO). Both glutathione
disulﬁde (GSSG) and GSNO possess mycobactericidal activities in vitro. In this study we demonstrate
that M. tuberculosis thioredoxin system, comprises of thioredoxin reductase B2 and thioredoxin C
reduces the oxidized form of the intracellular mycothiol (MSSM) and is able to efﬁciently reduce
GSSG and GSNO in vitro. Our study suggests that the thioredoxin system provide a general reduction
mechanism to cope with oxidative stress associated with the microbe’s metabolism as well as to
detoxify xenobiotics produced by the host.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Mycobacterium tuberculosis, the causative agent of tuberculosis,
is a human intracellular pathogen responsible for two million
deaths worldwide per annum [1]. M. tuberculosis infects, resides,
and multiplies in alveolar macrophages and causes the formation
of granulomas, which surround the bacilli to limit their dispersion.
Within granulomas and phagosomes, M. tuberculosis is exposed to
reactive oxygen intermediates (ROIs) and reactive nitrogen inter-
mediates (RNIs), which generate a toxic environment aimed to kill
the pathogen. In turn, M. tuberculosis employs multiple strategies
to combat oxidative stress, which include a catalase/peroxidase en-
zyme (KatG) [2], superoxide dismutase [3] and a thiol based detox-
iﬁcation response [4].
In eukaryotes, glutathione (GSH) maintains a reducing environ-
ment within the cytoplasm, and is a key component of the cellularchemical Societies. Published by E
c acid); GSH, glutathione; GS-
ulﬁde; GSNO, S-nitrosogluta-
mobimane; MSH, mycothiol;
zed mycothiol (mycothione);
nitrogen intermediates; ROI,
ay).defense against oxygen toxicity [4]. M. tuberculosis lacks GSH and
instead uses mycothiol (MSH), which functions as the mycobacte-
ria’s main anti-oxidant defense [4].
Thioredoxin systems [5] are key ubiquitous thiol-disulﬁde
oxidoreductases. The thioredoxin system is composed of thiore-
doxins and thioredoxin reductases, which transfer electrons from
NADPH to terminal oxidized substrates and protein disulﬁdes [6].
Thioredoxin systems are essential for various metabolic pathways
including the maintenance of a reduced state, DNA synthesis, and
transcription regulation in cells [7]. Thioredoxins are small pro-
teins, which possess a conserved CXXC catalytic motif that forms
an active center dithiol and undergoes reversible oxidation. The re-
dox cascade is based on the NADPH oxidation by thioredoxin
reductases, which mediates reduction of oxidized thioredoxins
[Trx-(S)2] and forms reduced thioredoxin-(SH)2. Finally, this re-
duced thioredoxin reduces a terminal substrate at the end of the
cascade.
The M. tuberculosis genome encodes three thioredoxins (TrxA,
TrxB1 and TrxC) and a single copy of the thioredoxin reductase
TrxB2 (TrxR) [8]. The system comprising TrxR and TrxC was shown
to reduce dinitrobenzene (DTNB), and hydroperoxides [9]. The thi-
oredoxin system contributes to the pathogen’s defense against
ROIs [2,5] by the reduction of the alkyl hydroperoxidase (ahpC).
The thioredoxin system also plays a role in hydroperoxide and per-
oxynitrite detoxiﬁcation by supplying electrons to the thiol perox-
idase Tpx [5].lsevier B.V. All rights reserved.
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tric oxide (NO) and GSH production. NO was shown to inhibit M.
tuberculosis growth both in vitro and in vivo [10,11]. GSH protects
macrophages against the toxic effect of ROIs and RNIs that are pro-
duced by the host in response to infection [12]. NO reacts with GSH
leading to generation of S-nitrosoglutathione (GSNO). Interest-
ingly, both GSNO and glutathione disulﬁde (GSSG) were shown
to be toxic to M. tuberculosis [13]. Mechanistically it has been as-
sumed that exposure to high concentrations of GSSG and GSNO
renders an imbalance in redox potential leading to M. tuberculosis
growth inhibition [14]. Although GSSG and GSNO are bactericidal
to M. tuberculosis in vitro, the pathogen can still survive and
multiply inside macrophages. This suggests that M. tuberculosis
possesses a detoxiﬁcation system to cope with these toxic agents.
In this study, we show that the thioredoxin system of M. tuber-
culosis possesses oxidoreductase activity towards various low
molecular weight (LMW) thiols. We provide evidence that this sys-
tem has the capacity to reduce GSSG and GSNO in vitro. This ﬁnd-
ing suggests that the thioredoxin system may potentially protect
M. tuberculosis against these antimycobacterial compounds. We
also demonstrate that this system efﬁciently reduces the oxidized
form of mycothiol (MSSM) in vitro , which is suggestive of the
potential role of the thioredoxin system to restore MSH levels
under oxidative stress.
2. Materials and methods
2.1. Gene cloning and production of recombinant proteins
The trxR, trxC and tpx genes were ampliﬁed by PCR from geno-
mic DNA ofM. tuberculosisH37Rv using the primers (Operon) listed
in Table 1. The trxC and tpx genes were ligated to pET-22b (Nova-
gen) after digestion with NdeI and HindIII. The resulting constructs
were transformed into Escherichia coli DH5a and conﬁrmed by
sequencing. The trxC/pET and tpx/pET constructs were subse-
quently transformed into E. coli BL-21 (DE3) for protein expression
and cultured in Luria–Bertani (EMD) medium supplemented with
100 lg/ml ampicillin (Fisher). trxR was ligated to the E. coli/Myco-
bacterium shuttle vector pALACE [15] after digestion with AﬂII and
ClaI. Once the construct was conﬁrmed by sequencing, it was elec-
troporated into Mycobacterium smegmatis mc2155 and cultured in
Middlebrook 7H9 (BD) supplemented with 0.05% Tween 20 (Fish-
er), 1% glucose, and 50 lg/ml hygromycin (Roche).Table 1
Strains, plasmids and oligonucleotides used in this work.
Strain, plasmid/oligonucleotides Characteristics
Strain
E. coli DH5a
E. coli BL21
M. smegmatis mc2155
Plasmids
pALACE ace promoter, hy
pET-22b PT7-based express
trxR/pALACE Rv3913 within Aﬂ
trxC/pET-22b Rv3914 within Nd
tpx/pET-22b Rv1932 within Nd
Oligonucleotides used in this work
trxR-forward 50-aaacttaagat
trxR-reverse 50-aaaatatcgat
trxC-forward 50-aattctagaca
trxC-reverse 50-aaaaagcttgt
tpx-forward 50-aattctagaca
tpx-reverse 50-aaaaagcttgg
trxC-Cys40Ser-forward 50-acatggtgtgg
trxC-Cys40Ser-reverse 50-gggcgctaccaProtein expression in E. coli and M. smegmatis was performed
according to published protocols [16,17]. Recombinant proteins
were puriﬁed as his-tagged proteins using Ni-NTA afﬁnity chroma-
tography (Qiagen) following the manufacturer protocols. Eluted
proteins were dialyzed overnight in 50 lM Tris–HCl pH 7.5,
1 mM dithiothreitol, 5% glycerol, and stored at 20 C.
2.2. Enzymatic assays
The reaction mixture contained 100 lM phosphate buffer pH
7.4, 1 mM EDTA (Sigma), 450 lM NADPH (ICN), and puriﬁed pro-
teins at a ﬁnal concentration of 1 lM in a ﬁnal volume of 0.6 ml.
GSSG (Sigma) and GSNO (Sigma) were assayed at 26 lM, while
H2O2 was used at a ﬁnal concentration of 5 lM. A thiol-containing
crude extract fromM. smegmatis (6 mM as assayed by HPLC [18]) at
a ﬁnal concentration of 26 lM was used to evaluate the activity of
the system towards MSSM. The activity of the thioredoxin system
was measured by spectrophotometry in two procedures. First pro-
cedure is based on the assay described by Holmgren [19], which
measures the decrease in A340 during the ﬁrst minute of reaction
every 10 s. The amount of NADPH oxidized was calculated as nmo-
les/min and according to the relation D340  0.6/6.2. In the second
procedure, 5,50-dithiobis-(2-nitrobenzoic acid) (DTNB) was the
substrate at a ﬁnal concentration of 26 lM [20], and followed by
measuring the increase in A412. One unit of activity was calculated
according to the relation D412  0.6/13.6  2 [21]. All the experi-
ments were performed in triplicate.
2.3. Biochemical assays using HPLC analyses
A typical reaction for kinetic studies contained the concentra-
tions 26, 40, and 57 lM of each substrate. All the biochemical as-
says were performed in triplicate. Formation of products from
each substrate was analyzed by HPLC according to published
protocols [18]. Brieﬂy, reactions were performed at 30 C, and ali-
quots of 200 ll were taken at time 0, 10, and 60 min. These ali-
quots were treated at 60 C with the ﬂuorescent alkylating agent
monobromobimane (mBBr) to produce the ﬂuorescent bimane
derivatives (S-conjugates) MS-mB and GS-mB from MSSM and
GSSG/GSNO, respectively. The treated samples were centrifugated
at 14000 rpm for 3 min and subsequently acidiﬁed with 2 ll of
5 M methanesulphonic acid (Sigma). At each time point an aliquot
of each reaction was taken for treatment with n-ethylmaleimideSource
Invitrogen
Invitrogen
ATCC 700084
gromycinR [15]
ion vector Novagen
II/ClaI restriction sites This work
eI/HindIII restriction sites This work
eI/HindIII restriction sites This work
gaccgccccgcctgt-30
tcatcgttgtgctcctatca-30
tatgaccgattccgagaagt-30
tgaggttgggaacc-30
tatggcacagataaccctgc-30
cgcccagcgcg-30
acctagcaagatggtagcgccc-30
tcttgctaggtccacaccatgt-30
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able thiol groups [22]. Samples were then resolved on reverse
phase Symmetry C18 column (250 mm  4.6 mm) (Waters) using
0.25% glacial acetic acid pH 3.6 (solvent A), and methanol (solvent
B). Separation of products was carried out by using 10% solvent B
for 10 min, 18% solvent B for 15 min, and 27% solvent B for another
22 min. The amount of product produced was calculated using a
calibration curve.
2.4. Generation of a catalytic-defective TrxC
A catalytic-defective TrxC was constructed by replacing the cys-
teine at position 40 with serine using the primers listed in Table 1.
The mutation Cys40Ser was performed by oligonucleotide overlap-
ping according to published protocols [23]. This mutation renders
TrxC unable to transfer electrons to a ﬁnal electron acceptor. The
mutation was conﬁrmed by sequencing.Fig. 1. Scheme of NADPH-dependent transfer of electrons to the terminal acceptors
mediated by thioredoxin system. (A) NADPH-driven reduction of GSSG, (B)
breakdown of GSNO, (C) reduction of MSSM.3. Results
3.1. Production of recombinant proteins
His-tagged TrxR (35 kDa), TrxC (12 kDa), TrxC-Cys40Ser
(12 kDa), and Tpx (16.8 kDa) were produced as recombinant solu-
ble proteins and puriﬁed using afﬁnity chromatography. Fig. 2
shows that all proteins migrated according to the expected size.
3.2. Reductase activity of recombinant thioredoxin system
DTNB and H2O2 act as substrates for the thioredoxin system
[5,9,24], and were used as positive controls to test the perfor-
mance of our system. When DTNB was used as the terminal elec-
tron acceptor, the thioredoxin system was able to oxidize NADPH
(Table 2). Upon addition of Tpx to the reaction, an approximate
50% increase in NADPH oxidation was observed. TrxR and its
combination with Tpx showed NADPH oxidation, which is in
agreement with previous reports [5,24]. Individual enzymes did
not show any activity except for TrxR, which shows a 90% de-
crease in the reductase activity as compared to the thioredoxin
system. No activity was measured when the parental TrxC was
replaced with the mutated Cys40Ser TrxC, as this catalytic-defec-
tive enzyme is not able to transfer electrons to the ﬁnal electron
acceptor.
Similarly, the thioredoxin system oxidized NADPH when H2O2
was used as a terminal substrate. An increase of 35% in NADPH
oxidation was measured when Tpx was added to the system. No
activity was measured when either individual enzymes or
combination of TrxR and Tpx were tested. Moreover, Cys40Ser TrxC
was not able to transfer electrons to the terminal acceptor sub-
strate H2O2.Table 2
NADPH-dependent disulﬁde reductase activity of M. tuberculosis thioredoxin system.
Protein DTNB H2O2
TrxR 42.9 ± 7.1 N.D.
TrxC N.D. N.D.
Tpx N.D. N.D.
TrxR + TrxC 406 ± 20 130 ± 5
TrxR + Cys40Ser TrxC 63 ± 6.6 N.D.
TrxR + Tpx 92 ± 2.4 N.D.
TrxC + Tpx N.D. N.D.
TrxR + TrxC + Tpx 606 ± 26 177 ± 3.6
TrxR + Cys40Ser TrxC + Tpx 83.3 ± 2.3 N.D.
Results are expressed as nmoles of NADPH oxidized/min ml mg protein.
N.D. = No Detected. Shown is the mean ± S.E. of three independent experiments.3.3. MSSM, GSSG and GSNO are substrates of thioredoxin system
Since MSH is the major LMW thiol within the mycobacterial
cell, we tested whether the thioredoxin system is able to reduce
MSSM (Fig. 1). Results from NADPH oxidation assay showed that
the thioredoxin system was able to recruit MSSM as the ﬁnal elec-
tron acceptor (Table 3). Addition of Tpx to the reaction led to a de-
crease in NADPH oxidation towards MSSM. No reductase activity
was detected when either individual enzymes or Cys40Ser TrxC
were used (data not shown).
The activity of the thioredoxin system towards GSSG and GSNO
(Fig. 1) was assessed by the NADPH oxidation assay. Results
showed that the thioredoxin system was able to transfer electrons
from NADPH to both GSSG and GSNO (Table 3). Upon addition of
Tpx to the system, a decrease in NADPH oxidation was measured
towards both substrates. No NADPH oxidation was detected when
either individual enzymes or Cys40Ser TrxC were used (data not
shown). Thus, we concluded that the thioredoxin system com-
prised of TrxR and TrxC has the capacity to transfer electrons from
NADPH to the three examined substrates GSSG, GSNO, and MSSM.
3.4. Direct measurements of product formation
HPLC analysis was performed [18] to directly measure the
amount of product formed in the enzymatic reaction, and to com-
paratively assess the oxidoreductase activity of the thioredoxinFig. 2. Puriﬁcation of redox proteins using afﬁnity Ni-NTA afﬁnity chromatography.
Elution fractions corresponding to puriﬁcations by afﬁnity chromatography were
resolved on 15% SDS–PAGE and Commassie blue stained. Lanes: (M) Protein marker,
(1) wt TrxC, (2) Cys40Ser mutated TrxC, (3) Tpx, (4) TrxR, (5) uninduced culture
(representative). Molecular weight of protein standards is indicated on left side.
Table 3
Speciﬁc reductase activity of the M. tuberculosis thioredoxin system towards selected
substrates.
GSSG GSNO MSSM
NADPH oxidation^
TrxR + TrxC 139 ± 8.3 120 ± 3 50 ± 5.6
TrxR + TrxC + Tpx 70 ± 6.6 63 ± 2 15 ± 1.3
HPLC analysis^^
TrxR + TrxC 150 ± 46 103 ± 27 49 ± 3
TrxR + TrxC + Tpx 103 ± 16 90 ± 29 18 ± 2
Results are expressed as: ^nmoles of NADPH oxidized/min ml mg enzyme, and
^^nmoles of thiol produced/min ml mg protein. Shown is the mean ± S.E. of three
independent experiments.
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TrxR, and NADPH, GSH was produced from both GSSG and GSNO
(Fig. 3 and Table 3). The thioredoxin system was able to produce
150 and 103 nmoles of GSH/ml min mg of protein when GSSG
and GSNO were used, respectively. However, upon addition ofFig. 3. Time-dependent formation of thiols by thioredoxin systems. The formation of thio
presence of 26 lM of each substrate. Reactions were stopped, acidiﬁed, labeled with mB
thiol-blocking compound and was used as negative control.Tpx to the system, a decrease in the rate of GSH formation was ob-
served. In the case of MSSM, 49 nmoles of MSH/ml min mg of pro-
tein were formed, but addition of Tpx to the system decreased the
rate of MSH formation. In addition, in all cases where Cys40Ser TrxC
was used, neither GSH nor MSH formation was detected (data not
shown).
3.5. Determination of kinetic parameters
To compare the efﬁciency of the thioredoxin system towards
the selected substrates, we determined the kinetic parameters of
the reactions. Kinetic results listed in Table 4 show that MSSM
has the highest afﬁnity to the thioredoxin system. The thioredoxin
system showed a similar turnover number towards GSSG and
GSNO with 352 and 298 molecules of substrate converted to
GSH min1, respectively, while 60 molecules of MSSM were con-
verted to MSHmin1 by the system. When Tpx was added to the
system, 168 and 245 molecules of GSSG and GSNO were converted
to GSH min1, while 46 molecules of MSSM were converted to
MSHmin1.ls over time was monitored by HPLC. Reactions were incubated at 37 C for 60 min in
Br, and separated in HPLC. Arrows indicate the position of MS-mB. NEM is a speciﬁc
Table 4
Steady-state kinetic parameters of substrate conversion.
Substrate KM (lM) Kcat (min1) Kcat/KM (min1 lM1)
GSSG
TrxR + TrxC 8.8 ± 2.7 352 40
TrxR + TrxC + Tpx 1.5 ± 0.9 168 112
GSNO
TrxR + TrxC 3.7 ± 0.9 298 80
TrxR + TrxC + Tpx 1.6 ± 0.13 245 153
MSSM
TrxR + TrxC 0.8 ± 0.1 60 75
TrxR + TrxC + Tpx 0.4 ± 0.18 46 115
Shown is the mean ± S.E. of three independent experiments.
Table 5
Kinetic parameter comparison of different thioredoxin systems.
Substrate Organism Kcat
(min1)
Kcat/KM
(min1 lM1)
Reference
GSSG M. tuberculosis 352 40 This work
Plasmodium falciparum <0.2 <0.00001 [32]
GSNO M. tuberculosis 298 80 This work
Human TrxC 36 0.6 [27]
Plasmodium falciparum 9.4 0.3 [32]
MSSM M. tuberculosis
thioredoxin system
60 75 This work
M. tuberculosis mycothiol
reductase
64 55 [33]
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Using both an NADPH oxidation assay and HPLC analysis of
product formation, we showed that the M. tuberculosis thioredoxin
system is able to transfer electrons in vitro to various substrates
including the intracellular substrate MSSM and the antimycobacte-
rial GSSG and GSNO.
According to our results, the number of nmoles of NADPH oxi-
dized by the thioredoxin system towards the candidate substrates
was consistent with the number of nmoles of GSH or MSH formed
in the enzymatic reactions as measured by HPLC analysis (Table 3).
Also, higher levels of NADPH oxidation and product formation to-
wards GSSG and GSNO were observed by the thioredoxin system
in the absence of Tpx. This observation is consistent with the high-
er Kcat values of the thioredoxin system, which converts more mol-
ecules of substrate to product in the absence of Tpx. One
explanation of the lower activity of the system once Tpx was sup-
plemented to the thioredoxin system is the formation of disulﬁde
bridges between Tpx-Cys60, TrxR-Cys31 and TrxC-Cys37 [25]. Then,
since the substrate of Tpx (H2O2) is absent in this reaction, we sug-
gest that there is a transient binding of Tpx to TrxC. This eventually
reduces the number of available catalytic sites of TrxC thus
decreasing the thioredoxin activity in the presence of Tpx.
Our study suggests a novel function for the M. tuberculosis thi-
oredoxin system acting as a GSNO reducing system. Denitrosyla-
tion of GSNO by human thioredoxins has been studied by both
the Holmgren and Stoyanovsky laboratories. Holmgren’s group
has reported a homolytic breakdown of GSNO generating GSH
and NO [27], while Stoyanovsky has proposed a heterolytic break-
down of GSNO producing GSH and nitroxyl (HNO) [28]. However
both groups suggest that other cellular nitrosylated proteins may
serve as substrates for the thioredoxin system. Earlier attempts
to elucidate the mechanism of GSNO breakdown in M. tuberculosis
suggested that the only enzyme inM. tuberculosiswith nitrosothiol
reductase activity is S-nitrosomycothiol reductase (MscR), which is
responsible for S-nitrosomycothiol reduction [26]. However, MscR
is unable to utilize GSNO as a substrate.
As mentioned earlier, we present evidence that the M. tubercu-
losis thioredoxin system catalyzes the denitrosylation of GSNO,
resulting in the formation of GSH. The consequence of this break-
down and the mechanism of inactivation of NO intermediates re-
leased from GSNO inside the pathogen remains to be elucidated.
Production of the toxic NO as the result of GSNO breakdown seems
paradoxical, due to the toxicity of NO [29]. However, bearing in
mind the short half life of NO, and our previous studies showing
that mycothiol efﬁciently protects mycobacteria against its bacte-
ricidal effect [11], NO is considered much less toxic compared to
GSNO [30].
The mycobacterial thioredoxin system shows higher kinetic
parameters (Kcat and Kcat/KM) values compared to other thiore-
doxin systems, e.g. human thioredoxins or the protozoan parasitePlasmodium falciparum thioredoxin systems (Table 5). This obser-
vation suggests that the mycobacterial thioredoxin system is able
to efﬁciently reduce GSSG and its nitroso derivative GSNO of the
host.
Under oxidative stress MSH becomes oxidized and forms the
oxidized MSSM disulﬁde. Mycothiol reductase (Mtr) reduces
MSSM and maintains MSH levels [31]. However, Mtr is not an
essential gene inM. tuberculosis, suggesting that other electron do-
nors can restore MSH. Here, we show that the thioredoxin system
reduces MSSM, with an efﬁciency comparable to Mtr.
In conclusion, our in vitro results show that the thioredoxin sys-
tem of M. tuberculosis functions as a general reduction system,
which is able to efﬁciently reduce the LMW disulﬁdes GSSG and
MSSM, and dissimilate GSNO. Our ﬁndings suggest that this system
may potentially be involved in the detoxiﬁcation of mycobacteri-
cidal compounds such as GSSG and GSNO, which are produced
by macrophages to limit mycobacterial growth within the infected
host. Additional work is in progress to characterize the activity of
the thioredoxin system in infected macrophages.
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